Mycoplasma testing is the process of identifying contamination which can have major effects on cell line growth and characteristics. Global mycoplasma testing market value is projected to be $523.3 Million in 2017 and is expected to generate revenue of around $1193 Million by the end of 2024, growing at a CAGR of around 12.50% between 2019 and 2024. Rising cell culture contamination and the strong trend of R&D investments in life sciences are the factors enhancing the growth of the market. Shortage of skilled professionals and a high degree of consolidation acts as an entry barrier for new entrants are the factors which hamper the market growth. Private exchanges providing great market potential and increasing pharmaceutical outsourcing are the opportunities for mycoplasma testing market.
Research Study Objectives:
- Define, estimate, and forecast the mycoplasma testing market statistics by product & service, application, techniques, end user and regions concerning the individual growth drivers, market trends and their contribution toward the mycoplasma testing market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific, South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the mycoplasma testing market analysis report.
- Analysis and conclusions on the future mycoplasma testing market outlook.
Top-down and bottom-up approaches are used to validate the mycoplasma testing market size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the
market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The mycoplasma testing market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the mycoplasma testing market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The mycoplasma testing market segmentation is as follows:
By Technique
- PCR
- Elisa
- Direct assays
- Indirect assays
- DNA staining
- Microbial culture techniques
- Enzymatic methods
By Application
- Cell line testing
- Virus testing
- End-of-production cell testing
- Other applications
By Product & Service
- Kits & reagents
- Instruments
- Services
By End User
- Pharmaceutical and biotechnology companies
- Contract research organizations
- Academic research institutes
- Cell banks
- Other end users
Geographical Analysis:
Mycoplasma testing market is segmented by geography into North America, South America, Europe, Asia Pacific and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. The Asia Pacific is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging
nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the mycoplasma testing market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Mycoplasma Testing Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant mycoplasma testing market players, such as
- Thermo Fisher Scientific, Inc.
- The Merck Group
- Promo Cell GmbH.
- American Type Culture Collection.
- Charles River Laboratories International, Inc.
- Along with these companies, many other companies are considered in the report while analysing the global mycoplasma testing competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
